ESKAZOLE 400 mg, tablet 60 tablets
Active ingredients: Albendazol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Tablet60 tabletsorale
Out of stock
Package details
Original BDPM fields are shown in French.
- Official name
- ESKAZOLE 400 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68879708CIP73686742CIP133400936867420Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALBENDAZOLEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.